A comprehensive view of Novartis AG. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Logistic & Supply Chain Market Intelligence Service.
Australia Patent: NOVARTIS Files Application for 'Antibody drug conjugates and methods for making thereof'
Published:
April 19, 2024
by Australian Government
|
Australia: Novartis Receives Patent for '2-azaspiro(3.4)octane derivatives as M4 agonists'
Published:
April 19, 2024
by Australian Government
|
Australia Patent: Novartis Files Application for 'Use of an anti-P-selectin antibody'
Published:
April 19, 2024
by Australian Government
|
US Patent Issued to Novartis on April 16 for "Solid forms comprising an oxime ether compound, compositions and methods of use thereof" (New Jersey Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
US Patent Issued to Novartis on April 16 for "Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors" (American, Canadian Inventors)
Published:
April 17, 2024
by U.S. Fed News
|
Ask us about our Logistic & Supply Chain market view